Foley Hoag Panelists to Discuss Latest Legal, Regulatory Issues at BIO International Convention
June 2, 2011
Partners and a senior health policy specialist from Foley Hoag LLP will discuss legal and regulatory issues affecting the biotechnology and pharmaceutical industries at the 2011 BIO International Convention from June 27-30 at the Walter E. Washington Convention Center in Washington, DC.
The panel discussions will include:
• “Common Needs” and Uncommon Cooperation: The State of Joint FDA and CMS Initiatives. Partner Paul Kim will moderate this panel that will highlight recent, key initiatives and explore steps being taken to improve communications, efficiencies and the quality of agency decision-making at the Food and Drug Administration and Centers for Medicare and Medicaid Services. The panel will be held June 28 from 10-11:30 a.m.
• Current Challenges in Payment System Reform. Partner Tom Barker will join a panel that will attempt to provide an overview of the likely proposals under consideration to reform payment systems and explore their potential impact on the biotechnology and pharmaceutical industries. The panel will be held June 28 from 2-3:30 p.m.
• Advanced Molecular Diagnostics: Reforming Regulation and Reimbursement. Foley Hoag senior health policy specialist Bruce Quinn will provide an overview of the prospects for changes in the regulation and reimbursement of advanced molecular diagnostics. The panel will be held June 30 from 10-11:30 a.m.
Foley Hoag, which is a sponsor of the 2011 BIO International Convention, also is a co-sponsor of the Achieving Regulatory Approval & Compliance session track with Eli Lilly & Company. Attendees at the BIO International Convention, the largest global event for the biotechnology industry, may visit the Foley Hoag booth (Booth #3017) to get the latest information on the firm’s life sciences services.
Foley Hoag also is hosting a cocktail reception for guests at the Newseum in Washington, DC, on June 28 at 6:30 p.m.
About Foley Hoag LLP
Foley Hoag is a dynamic law firm that represents public and private clients in a wide range of disputes and transactions worldwide. We have expertise in industries such as life sciences and healthcare, technology, energy and renewables, investment management, and professional services. We also offer our clients market-leading international litigation and arbitration and corporate social responsibility services. From our offices in Boston, Washington, D.C. and Paris, and our Emerging Enterprise Center in Waltham, Massachusetts, we provide strategic legal advice that is tailored to each of our client’s unique goals. Foley Hoag combines powerful regional, national and international practices that share a common emphasis on client service. We are focused on what we do best: helping our clients succeed through the delivery of exceptional legal service. For more information, visit www.foleyhoag.com.
CATEGORIES
Life Sciences, Venture Capital & Emerging Companies, Healthcare, Government Strategies, Intellectual Property, Intellectual Property Litigation, International, Licensing & Strategic Alliances, Medicare Coverage & Payment For New Technologies, Patent